Pro-inflammatory cytokines in Omani type 2 diabetic patients presenting anxiety and depression

Iranian Journal of Immunology

Volumn 7, Issue 2, 2010, Pages 124-129

  Al Maskari, Masoud ^a   Al Shukaili, Ahmed ^a   Al Mammari, Ali ^a  

^a SULTAN QABOOS UNIVERSITY   (Oman)

Author keywords

Antibodies; Anxiety; Depression; Inflammatory markers; Type 2 Diabetes

Indexed keywords

C REACTIVE PROTEIN; GAMMA INTERFERON; GLUTAMATE DECARBOXYLASE 65 ANTIBODY; INTERLEUKIN 1BETA; THYROID PEROXIDASE ANTIBODY; TUMOR NECROSIS FACTOR ALPHA; AUTACOID; AUTOANTIBODY; CYTOKINE; GLUTAMATE DECARBOXYLASE; GLUTAMATE DECARBOXYLASE 2;

ADULT; ANXIETY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OMAN; PROTEIN FUNCTION; QUESTIONNAIRE; SELF REPORT; BLOOD; GENETICS; IMMUNOLOGY; METABOLISM; MIDDLE AGED; PREVALENCE; PSYCHOLOGICAL ASPECT;

ADULT; ANXIETY; AUTOANTIBODIES; C-REACTIVE PROTEIN; CYTOKINES; DEPRESSION; DIABETES MELLITUS, TYPE 2; FEMALE; GLUTAMATE DECARBOXYLASE; HUMANS; INFLAMMATION MEDIATORS; MALE; MIDDLE AGED; OMAN; PREVALENCE;

EID: 79952294786     PISSN: 17351383     EISSN: 1735367X     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Anderson RJ, Freedland KE, Clouse RE, Lustman PJ. The prevalence of comorbid depression in adults with diabetes: a metaanalysis. Diabetes Care. 2001; 24:1069-78.
2. Anisman H. Cascading effects of stressors and inflammatory immune system activation: implications for major depressive disorder. J Psychiatry Neurosci. 2009; 34:4-20.
3. Barzilay JI, Abraham L, Heckbert SR, Cushman M, Kuller LH, Resnick HE et al. The relation of markers of inflammation to the development of glucose disorders in the elderly: the Cardiovascular Health Study. Diabetes. 2001; 50:2384-9.
4. Dantzer R. Cytokine, sickness behavior, and depression, Neurol Clin. 2006; 24:441-60.
5. Hundal RS, Petersen KF, Mayerson AB, Randhawa PS, Inzucchi S, Shoelson SE et al. Mechanism by which high-dose aspirin improves glucose metabolism in type 2 diabetes. J Clin Invest. 2002; 109:1321-6.
6. Engum A, Mykletun A, Midthjell K, Holen A, Dahl AA. Depression and diabetes: a large population-based study of sociodemographic, lifestyle, and clinical factors associated with depression in type 1 and type 2 diabetes. Diabetes Care. 2005; 28:1904-9.
7. Festa A, D'Agostino R Jr, Tracy RP, Haffner SM. Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: the insulin resistance atherosclerosis study. Diabetes. 2002; 51:1131-7.
8. Freeman DJ, Norrie J, Caslake MJ, Gaw A, Ford I, Lowe GD et al. C-reactive protein is an independent predictor of risk for the development of diabetes in the West of Scotland Coronary Prevention Study. Diabetes. 2002; 51:1596-600.
9. Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA. 2001; 286:327-34.
10. World Health Organization. Difinition, diagnosis and classification of diabtes mellitus and its complications Part 1: Diagnosis of Diabetes Mellitus, Report of a WHO Consultation. Geneva: Department of Noncommunicable Disease Surveilance, World Health Organisation.1999.
11. Zigmond AS, Snaith RP. The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand. 1983; 67:361-70.
12. Snaith RP, Zigmond AS. The Hospital Anxiety and Depression Scale Manual Windsor, Ontario, Canada, NFER-Nelson. 1994.
13. Schmidt MI, Duncan BB, Sharrett AR, Lindberg G, Savage PJ, Offenbacher S, et al. Markers of inflammation and prediction of diabetes mellitus in adults (Atherosclerosis Risk in Communities study): a cohort study. Lancet. 1999; 353:1649-52
14. Spranger J, Kroke A, Möhlig M, Hoffmann K, Bergmann MM, Ristow M, et al. Inflammatory cytokines and the risk to develop type 2 diabetes: results of the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study. Diabetes. 2003; 52:812-7.
15. Hao W, Palmer JP. The effect of cytokines on expression of glutamic acid decarboxylase-65 in cultured islets. Autoimmunity. 1995; 22:209-18.
16. Yuan M, Konstantopoulos N, Lee J, Hansen L, Li ZW, Karin M, Shoelson SE. Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of Ikkbeta. Science. 2001; 293:1673-7.
17. Kim JK, Kim YJ, Fillmore JJ, Chen Y, Moore I, Lee J, et al. Prevention of fat-induced insulin resistance by salicylate. J Clin Invest. 2001; 108:437-46.
18. de Groot M, Anderson R, Freedland KE, Clouse RE, Lustman PJ. Association of depression and diabetes complications: a meta-analysis. Psychosom Med. 2001; 63:619-30.
19. Lustmann PJ, Anderson RJ, Freedland KE, De Groot M, Carney RM, Clouse RE: Depression and poor glycemic control: A meta-analytic review of the literature. Diabetes Care. 2000; 23:934-42.
20. Kruse J, Schmitz N, Thefeld W. German National Health Interview and Examination Survey on the association between diabetes and mental disorders in a community sample: results from the German National Health Interview and Examination Survey. Diabetes Care. 2003; 26:1841-6.
21. Egede LE, Zheng D. Independent factors associated with major depressive disorder in a national sample of individuals with diabetes. Diabetes Care.2003; 26:104-11.